NEW YORK STATE DEPARTMENT OF HEALTH 08/06 ... - eMedNY

More documents

Recommendations

Info

NEW YORK STATE DEPARTMENT OF HEALTH 02/28/2014 PAGE: 378LIST OF MEDICAID REIMBURSABLE DRUGSRX TYPE: 01 PRICING ERRORS ARE NOT REIMBURSABLE PRICES EFFECTIVE 02/28/2014LTM BASISIND NDC CODE MRA COST COST ALTERNATE FORMULARY DESCRIPTION PA CD LABELER OF MRA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 76388-0880-25 12.50976 TABLOID 40 MG TABLET 0 PRASCO LABS EABND 50222-0227-04 12.12630 TACLONEX OINTMENT G LEO PHARMA INC. GMBND 50222-0227-81 10.71696 TACLONEX OINTMENT G LEO PHARMA INC. GMBND 50222-0501-06 10.88696 TACLONEX 0.005%-0.064% SUSPENS G LEO PHARMA INC. GMBND 50222-0501-66 10.88696 TACLONEX 0.005%-0.064% SUSPENS G LEO PHARMA INC. GMGEN 00378-2045-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G MYLAN EAGEN 00378-2045-05 1.67235 TACROLIMUS 0.5 MG CAPSULE G MYLAN EAGEN 00781-2102-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G SANDOZ EAGEN 00781-9302-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G SANDOZ/NOVAPLUS EAGEN 16729-0041-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G ACCORD HEALTHCA EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 50742-0207-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G INGENUS PHARMAC EAGEN 51079-0817-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G MYLAN INSTITUTI EAGEN 51079-0817-20 1.67235 TACROLIMUS 0.5 MG CAPSULE G MYLAN INSTITUTI EAGEN 55111-0525-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G DR.REDDY'S LAB EAGEN 62175-0380-37 1.67235 TACROLIMUS 0.5 MG CAPSULE G KREMERS URBAN EAGEN 68084-0449-01 1.67235 TACROLIMUS 0.5 MG CAPSULE G AHP EAGEN 68084-0449-11 1.67235 TACROLIMUS 0.5 MG CAPSULE G AHP EAGEN 00378-2046-01 3.34462 TACROLIMUS 1 MG CAPSULE G MYLAN EAGEN 00378-2046-05 3.34462 TACROLIMUS 1 MG CAPSULE G MYLAN EAGEN 00781-2103-01 3.34462 TACROLIMUS 1 MG CAPSULE G SANDOZ EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 00781-9303-01 3.34462 TACROLIMUS 1 MG CAPSULE G SANDOZ/NOVAPLUS EAGEN 16729-0042-01 3.34462 TACROLIMUS 1 MG CAPSULE G ACCORD HEALTHCA EAGEN 50742-0208-01 3.34462 TACROLIMUS 1 MG CAPSULE G INGENUS PHARMAC EAGEN 51079-0818-01 3.34462 TACROLIMUS 1 MG CAPSULE G MYLAN INSTITUTI EAGEN 51079-0818-20 3.34462 TACROLIMUS 1 MG CAPSULE G MYLAN INSTITUTI EAGEN 55111-0526-01 3.34462 TACROLIMUS 1 MG CAPSULE G DR.REDDY'S LAB EAGEN 62175-0381-37 3.34462 TACROLIMUS 1 MG CAPSULE G KREMERS URBAN EAGEN 68084-0450-01 3.34462 TACROLIMUS 1 MG CAPSULE G AHP EAGEN 68084-0450-11 3.34462 TACROLIMUS 1 MG CAPSULE G AHP EAGEN 00378-2047-01 16.72312 TACROLIMUS 5 MG CAPSULE G MYLAN EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 00781-2104-01 16.72312 TACROLIMUS 5 MG CAPSULE G SANDOZ EAGEN 00781-9304-01 16.72312 TACROLIMUS 5 MG CAPSULE G SANDOZ/NOVAPLUS EAGEN 16729-0043-01 16.72312 TACROLIMUS 5 MG CAPSULE G ACCORD HEALTHCA EAGEN 50742-0209-01 16.72312 TACROLIMUS 5 MG CAPSULE G INGENUS PHARMAC EAGEN 51079-0028-01 16.72312 TACROLIMUS 5 MG CAPSULE G MYLAN INSTITUTI EAGEN 51079-0028-20 16.72312 TACROLIMUS 5 MG CAPSULE G MYLAN INSTITUTI EAGEN 55111-0527-01 16.72312 TACROLIMUS 5 MG CAPSULE G DR.REDDY'S LAB EAGEN 62175-0382-37 16.72312 TACROLIMUS 5 MG CAPSULE G KREMERS URBAN EAGEN 68084-0451-01 16.72312 TACROLIMUS 5 MG CAPSULE G AHP EAGEN 68084-0451-11 16.72312 TACROLIMUS 5 MG CAPSULE G AHP EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 00173-0846-08 44.15890 TAFINLAR 50 MG CAPSULE 0 GLAXOSMITHKLINE EABND 00173-0847-08 66.23400 TAFINLAR 75 MG CAPSULE 0 GLAXOSMITHKLINE EABND 00004-0802-85 10.10940 TAMIFLU 30 MG GELCAP 0 ROCHE LABS. EABND 00004-0801-85 10.10940 TAMIFLU 45 MG GELCAP 0 ROCHE LABS. EABND 00004-0820-09 1.83664 TAMIFLU 6 MG/ML SUSPENSION 0 GENENTECH, INC. ML** PRIOR APPROVAL CODES:PA code "0" = PA not required; PA code "N" = PA requiredPA code "G" = PA required for Non Preferred drugs OR drugs not meeting clinical criteria (FQD, STEP) OR drugs inClinical Drug Review Program, the Brand Less than Generic Program or the Mandatory Generic Program*** OTC, SUPPLY AND COMPOUND PRODUCTS LISTING AT BACK OF REPORT
NEW YORK STATE DEPARTMENT OF HEALTH 02/28/2014 PAGE: 379LIST OF MEDICAID REIMBURSABLE DRUGSRX TYPE: 01 PRICING ERRORS ARE NOT REIMBURSABLE PRICES EFFECTIVE 02/28/2014LTM BASISIND NDC CODE MRA COST COST ALTERNATE FORMULARY DESCRIPTION PA CD LABELER OF MRA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------BND 00004-0822-05 1.83664 TAMIFLU 6 MG/ML SUSPENSION 0 GENENTECH, INC. MLBND 00004-0800-85 11.01991 TAMIFLU 75 MG CAPSULE 0 ROCHE LABS. EAGEN 00093-0784-05 0.19642 TAMOXIFEN 10 MG TABLET 0 TEVA USA EAGEN 00093-0784-06 0.19642 TAMOXIFEN 10 MG TABLET 0 TEVA USA EAGEN 00093-0784-10 0.19642 TAMOXIFEN 10 MG TABLET 0 TEVA USA EAGEN 00093-0784-86 0.19642 TAMOXIFEN 10 MG TABLET 0 TEVA USA EAGEN 00378-0144-91 0.19642 TAMOXIFEN 10 MG TABLET 0 MYLAN EAGEN 00591-2472-18 0.19642 TAMOXIFEN 10 MG TABLET 0 ACTAVIS PHARMA, EAGEN 00591-2472-60 0.19642 TAMOXIFEN 10 MG TABLET 0 ACTAVIS PHARMA, EAGEN 00093-0782-01 0.43497 TAMOXIFEN 20 MG TABLET 0 TEVA USA EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 00093-0782-05 0.43497 TAMOXIFEN 20 MG TABLET 0 TEVA USA EAGEN 00093-0782-10 0.43497 TAMOXIFEN 20 MG TABLET 0 TEVA USA EAGEN 00093-0782-56 0.43497 TAMOXIFEN 20 MG TABLET 0 TEVA USA EAGEN 00378-0274-01 0.43497 TAMOXIFEN 20 MG TABLET 0 MYLAN EAGEN 00378-0274-93 0.43497 TAMOXIFEN 20 MG TABLET 0 MYLAN EAGEN 00591-2473-19 0.43497 TAMOXIFEN 20 MG TABLET 0 ACTAVIS PHARMA, EAGEN 00591-2473-30 0.43497 TAMOXIFEN 20 MG TABLET 0 ACTAVIS PHARMA, EAGEN 00093-7338-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 TEVA USA EAGEN 00115-8211-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 GLOBAL PHARM EAGEN 00115-8211-03 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 GLOBAL PHARM EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 00228-2996-11 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 ACTAVIS PHARMA, EAGEN 00228-2996-50 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 ACTAVIS PHARMA, EAGEN 00378-2500-10 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN EAGEN 00378-2500-77 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN EAGEN 00781-2076-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 SANDOZ EAGEN 00904-6156-61 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MAJOR PHARMACEU EAGEN 10370-0169-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 PAR PHARM. EAGEN 10370-0169-05 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 PAR PHARM. EAGEN 51079-0294-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EAGEN 51079-0294-17 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 51079-0294-19 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EAGEN 51079-0294-20 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EAGEN 51079-0294-30 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EAGEN 51079-0294-56 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MYLAN INSTITUTI EAGEN 62756-0160-13 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 SUN PHARMACEUTI EAGEN 62756-0160-81 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 SUN PHARMACEUTI EAGEN 62756-0160-88 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 SUN PHARMACEUTI EAGEN 63739-0811-41 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MCKESSON PACKAG EAGEN 63739-0811-43 0.14758 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MCKESSON PACKAG EAGEN 63739-0811-45 0.13779 TAMSULOSIN HCL 0.4 MG CAPSULE 0 MCKESSON PACKAG EA--- ------------- ------------ -------------- -------------------------------------------------- ----- ------------------ ----------GEN 64679-0516-02 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 WOCKHARDT USA L EAGEN 64679-0516-03 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 WOCKHARDT USA L EAGEN 65862-0598-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 AUROBINDO PHARM EAGEN 65862-0598-05 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 AUROBINDO PHARM EAGEN 68084-0407-01 0.17210 TAMSULOSIN HCL 0.4 MG CAPSULE 0 AHP EA** PRIOR APPROVAL CODES:PA code "0" = PA not required; PA code "N" = PA requiredPA code "G" = PA required for Non Preferred drugs OR drugs not meeting clinical criteria (FQD, STEP) OR drugs inClinical Drug Review Program, the Brand Less than Generic Program or the Mandatory Generic Program*** OTC, SUPPLY AND COMPOUND PRODUCTS LISTING AT BACK OF REPORT
Page 4 and 5:
NEW YORK STATE DEPARTMENT OF HEALTH
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329: NEW YORK STATE DEPARTMENT OF HEALTH
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Page 434 and 435:
Page 436 and 437:
Page 438 and 439:
Page 440 and 441:
Page 442 and 443:
Page 444 and 445:
Page 446 and 447:
Page 448 and 449:
Page 450 and 451:
Page 452 and 453:
Page 454 and 455:
Page 456 and 457:
Page 458 and 459:
Page 460 and 461:
Page 462 and 463:
Page 464 and 465:
Page 466 and 467:
Page 468 and 469:
Page 470 and 471:
Page 472 and 473:
Page 474 and 475:
Page 476 and 477:
Page 478 and 479:
Page 480 and 481:
Page 482 and 483:
Page 484 and 485:
Page 486 and 487:
Page 488 and 489:
Page 490 and 491:
Page 492 and 493:
Page 494 and 495:
Page 496 and 497:
Page 498 and 499:
Page 500 and 501:
Page 502 and 503:
Page 504 and 505:
Page 506 and 507:
Page 508 and 509:
Page 510 and 511:
Page 512 and 513:
Page 514 and 515:
Page 516 and 517:
Page 518 and 519:
Page 520 and 521:
show all

NEW YORK STATE DEPARTMENT OF HEALTH 08/06 ... - eMedNY

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?